XML 53 R31.htm IDEA: XBRL DOCUMENT v3.20.4

Shareholders' Equity (Deficit) (Tables)

12 Months Ended

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

Schedule of ordinary share capital

December 31, 2020

December 31, 2019

Authorized

Issued and outstanding

Authorized

Issued and outstanding

Number of shares

Ordinary shares with no par value

47,800,000

18,494,739

22,466,000

562,748

Schedule of status of options to employees

		Year ended December 31, 2020
		Number of options				Weighted average exercise price				Aggregate intrinsic value				Weighted  average  remaining  contractual life (years)
Outstanding at beginning of year			1,217,985			$	4.62			$	3,411				5.04
Granted			1,064,959				7.08
Exercised			(395	)			6.80				1
Forfeited and cancelled			(89,157	)			5.99
Outstanding at end of year			2,193,392			$	5.72			$	9,263				6.58
Exercisable options			1,306,421			$	4.78			$	6,686				4.63
Vested and expected to vest			2,193,392			$	5.72			$	9,263				6.58

		Year ended December 31, 2019
		Number of options				Weighted average exercise price				Aggregate intrinsic value				Weighted  average  remaining  contractual life (years)
Outstanding at beginning of year			1,234,955			$	4.59			$	4,608				5.96
Granted			82,216				8.04
Exercised			(1,523	)			4.54				4
Forfeited and cancelled			(97,663	)			6.50
Outstanding at end of year			1,217,985			$	4.62			$	3,411				5.04
Exercisable options			1,108,207			$	4.29			$	3,406				4.66
Vested and expected to vest			1,217,985			$	4.62			$	3,406				5.04

Schedule of equity-based awards recognized

		Year ended December 31,
		2020				2019				2018
Research and development			1,806				180				239
Marketing and business development			140				90				17
General and administrative			2,631				706				739
Total share-based compensation expense			4,577				976				995

Schedule of options outstanding

Exercise price ($)				Options outstanding as of December 31, 2020				Weighted average exercise price ($)				Weighted average remaining contractual term				Options exercisable as of December 31, 2020				Weighted average exercise price ($)				Weighted average remaining contractual term
												Years												Years
	*)0.22				249,561				*)0.22				2.21				249,561				*)0.22				2.21
	1.75				107,904				1.75				2.21				107,904				1.75				2.21
	3.59				83,503				3.59				2.33				83,503				3.59				2.33
	5.07				260,296				5.07				3.36				260,296				5.07				3.36
	9.23				200,229				9.23				4.88				200,229				9.23				4.88
	3.10				29,947				3.10				5.42				29,947				3.10				5.42
	3.93				51,385				3.93				5.98				51,385				3.93				5.98
	4.10				20,914				4.10				6.19				20,914				4.10				6.19
	4.18				1,195				4.18				6.40				1,195				4.18				6.40
	7.70				66,326				7.70				6.84				66,326				7.70				6.84
	8.42				7,589				8.42				7.78				5,461				8.42				7.77
	8.65				15,035				8.65				7.62				10,940				8.65				7.53
	8.02				46,069				8.02				8.30				35,004				8.02				8.32
	6.80				58,731				6.80				9.11				14,858				6.80				9.11
	6.62				904,608				6.62				9.45				168,898				6.62				9.44
	11.04				90,100				11.04				9.86				-				11.04				-
					2,193,392				5.72				6.58				1,306,421				4.78				4.63

Schedule of outstanding options granted

Grant date		Options outstanding as of December 31, 2020				Average Exercise price per share				Options exercisable as of December 31, 2020				Exercisable through
March 2013			22,258			$	1.76				22,258			March 2023
October 2013			5,719				5.06				5,719			October 2023
June 2014			5,617				5.06				5,617			June 2024
September 2014			5,719				5.06				5,719			September 2024
April 2016			5,975				3.10				5,975			April 2026
December 2016			7,170				3.93				7,170			March 2023
June 2017			197,722				4.10				136,594			June 2027
August 2017			5,617				9.29				5,617			August 2027
November 2017			17,925				7.70				17,925			March 2027
August 2019			71,700				8.18				64,195			August 2029
June 2020			88,430				6.62				-			June 2030
			433,852								276,789

X

- References

No definition available.

+ Details

Name:	pypd_ScheduleOfOptionOutstandingTablesTextBlock
Namespace Prefix:	pypd_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	pypd_ScheduleOfOutstandingOptionGrantedTablesTextBlock
Namespace Prefix:	pypd_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

+ Details

Name:	us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of long-lived, depreciable assets that are subject to a lease meeting the criteria for capitalization and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737

+ Details

Name:	us-gaap_ScheduleOfCapitalLeasedAsssetsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration